Adenohypophysis

The adenohypophysis, also known as the anterior pituitary, is a vital component of the endocrine system responsible for synthesizing and secreting multiple hormones that regulate growth, metabolism, reproduction, and stress response. Its intricate connection with the hypothalamus enables precise hormonal control and feedback mechanisms.

Embryology of Adenohypophysis

The adenohypophysis develops from an ectodermal upgrowth of the oral cavity known as Rathke’s pouch. This structure arises around the fourth week of embryonic development and gradually forms the anterior pituitary.

• Origin from Rathke’s pouch: The anterior pituitary originates from the roof of the primitive oral cavity, which proliferates to form Rathke’s pouch. The distal portion of this pouch eventually differentiates into the functional adenohypophysis.
• Developmental stages:
  • Initial formation as a small invagination of oral ectoderm
  • Separation from the oral cavity to form a distinct glandular structure
  • Cell differentiation into hormone-producing cell types
• Clinical significance of developmental anomalies: Failure of normal development can result in congenital conditions such as pituitary hypoplasia, Rathke’s cleft cysts, or septo-optic dysplasia, which may lead to hormonal deficiencies in childhood.

Anatomy of Adenohypophysis

The adenohypophysis is located in the sella turcica of the sphenoid bone, positioned anterior to the neurohypophysis. Its anatomical relationships and vascular supply are crucial for its endocrine function.

• Gross anatomy and location: The anterior pituitary constitutes approximately 75% of the total pituitary mass. It is situated below the hypothalamus, connected via the pituitary stalk.
• Relation to neurohypophysis and hypothalamus: The adenohypophysis lies anterior to the posterior pituitary and communicates with the hypothalamus through the hypophyseal portal system, allowing hypothalamic hormones to regulate anterior pituitary activity.
• Blood supply and portal circulation: The superior hypophyseal arteries form a capillary network in the median eminence, which drains into portal veins. These veins deliver hypothalamic releasing and inhibiting hormones directly to the adenohypophysis.
• Histological structure: The gland is composed of epithelial cells organized into cords and clusters, supported by a network of fenestrated capillaries. Cell types include acidophils, basophils, and chromophobes, each responsible for specific hormone secretion.

Cell Types and Hormone Production

The adenohypophysis contains specialized endocrine cells that produce distinct hormones, each playing a critical role in regulating various physiological processes. These cells are classified based on their staining properties and the hormones they secrete.

• Somatotrophs – Growth Hormone (GH): Acidophilic cells that synthesize and secrete growth hormone, which stimulates growth of bones and tissues, promotes protein synthesis, and regulates metabolism.
• Lactotrophs – Prolactin (PRL): Acidophilic cells responsible for producing prolactin, which is essential for mammary gland development and milk production in postpartum females.
• Corticotrophs – Adrenocorticotropic Hormone (ACTH): Basophilic cells that secrete ACTH, stimulating the adrenal cortex to produce glucocorticoids, primarily cortisol, which regulate stress response and metabolism.
• Thyrotrophs – Thyroid-Stimulating Hormone (TSH): Basophilic cells that release TSH, which controls thyroid gland function and the production of thyroid hormones.
• Gonadotrophs – Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH): Basophilic cells that regulate reproductive function, including gametogenesis and steroid hormone production in the gonads.
• Histological staining patterns: Acidophils stain red or pink with eosin, basophils stain blue or purple with hematoxylin, and chromophobes appear pale and may represent degranulated or inactive cells.

Regulation of Adenohypophysis

The activity of the adenohypophysis is tightly controlled by the hypothalamus and peripheral endocrine glands, ensuring proper hormonal balance and physiological homeostasis.

• Hypothalamic control via releasing and inhibiting hormones:
  • Growth hormone-releasing hormone (GHRH) stimulates GH secretion
  • Somatostatin inhibits GH and TSH secretion
  • Thyrotropin-releasing hormone (TRH) stimulates TSH and prolactin
  • Corticotropin-releasing hormone (CRH) stimulates ACTH secretion
  • Gonadotropin-releasing hormone (GnRH) regulates LH and FSH secretion
  • Prolactin-inhibiting hormone (dopamine) suppresses prolactin release
• Feedback mechanisms from peripheral endocrine glands: Hormones from target organs such as thyroid hormones, cortisol, sex steroids, and IGF-1 exert negative feedback on the hypothalamus and anterior pituitary to maintain hormonal balance.
• Neuroendocrine integration: The pituitary integrates neural signals, stress responses, and circadian rhythms to adjust hormone secretion according to physiological needs.

Physiology and Function

The adenohypophysis plays a central role in maintaining homeostasis by regulating growth, metabolism, reproduction, and stress responses through its hormone secretion. Each hormone has specific target organs and physiological effects.

• Role in growth and development: Growth hormone stimulates linear growth in children, enhances protein synthesis, and promotes muscle and bone development. It also influences lipid and carbohydrate metabolism.
• Regulation of metabolism: Thyroid-stimulating hormone controls thyroid hormone production, which regulates basal metabolic rate, thermogenesis, and energy utilization.
• Reproductive function and lactation: Gonadotropins (LH and FSH) control gametogenesis and sex steroid production, while prolactin supports mammary gland development and lactation.
• Stress response and adrenal function: ACTH stimulates cortisol release from the adrenal cortex, which is essential for stress adaptation, blood pressure regulation, and metabolism of carbohydrates, fats, and proteins.

Clinical Disorders of Adenohypophysis

Dysfunction of the adenohypophysis can lead to a wide spectrum of clinical disorders, depending on whether hormone production is excessive, deficient, or abnormal in timing.

• Hypopituitarism: Characterized by insufficient secretion of one or more anterior pituitary hormones, leading to growth retardation, hypothyroidism, adrenal insufficiency, hypogonadism, and sometimes diabetes insipidus if posterior pituitary is also affected.
• Hyperpituitarism:
  • Acromegaly and gigantism: Excess GH in adults and children respectively, causing abnormal skeletal and soft tissue growth.
  • Cushing’s disease: Excess ACTH leads to overproduction of cortisol, resulting in obesity, hypertension, and glucose intolerance.
  • Hyperprolactinemia: Elevated prolactin causes galactorrhea, menstrual disturbances, and infertility.
• Pituitary adenomas: Benign tumors of the anterior pituitary can be functional (hormone-secreting) or nonfunctional, presenting with endocrine abnormalities or mass effects such as visual field defects.
• Congenital anomalies: Include pituitary dwarfism, septo-optic dysplasia, and Rathke’s cleft cysts, often leading to early-onset hormonal deficiencies and developmental delays.

Diagnostic Evaluation

Accurate diagnosis of adenohypophysis disorders requires a combination of hormonal testing, imaging studies, and dynamic endocrine evaluations to identify the underlying cause and guide treatment.

• Hormonal assays: Measurement of serum levels of GH, IGF-1, ACTH, cortisol, TSH, thyroid hormones, prolactin, LH, FSH, and sex steroids helps determine deficiencies or excesses of anterior pituitary hormones.
• Imaging techniques – MRI and CT: Magnetic resonance imaging is the preferred modality to evaluate pituitary size, structure, and presence of adenomas or cysts. CT may be used if MRI is contraindicated or for bony assessment.
• Dynamic stimulation and suppression tests: These tests assess the functional capacity of the adenohypophysis and its feedback mechanisms. Examples include:
  • Insulin tolerance test for GH and ACTH reserve
  • TRH stimulation test for TSH and prolactin response
  • ACTH stimulation test to assess adrenal function
  • GnRH stimulation test for gonadotropin evaluation

Treatment and Management

Management of adenohypophysis disorders depends on the specific hormonal imbalance or structural lesion. Treatment may involve medical therapy, surgical intervention, or radiotherapy.

• Medical therapy: Hormone replacement therapy is used for deficiencies, including levothyroxine for hypothyroidism, hydrocortisone for adrenal insufficiency, sex steroids for hypogonadism, and recombinant GH for growth failure. Dopamine agonists or somatostatin analogues may be used to suppress excess hormone secretion.
• Surgical management of pituitary tumors: Transsphenoidal surgery is the standard approach for resecting pituitary adenomas causing mass effect or hormonal hypersecretion.
• Radiotherapy and emerging therapies: Stereotactic radiosurgery may be indicated for residual or recurrent tumors. Novel pharmacological agents and targeted therapies are under investigation to modulate pituitary hormone secretion with fewer side effects.

References

1. Guyton AC, Hall JE. Textbook of Medical Physiology. 14th ed. Philadelphia: Elsevier; 2021.
2. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 14th ed. Philadelphia: Elsevier; 2020.
3. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317(5):516-524.
4. Jameson JL, De Groot LJ. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia: Elsevier; 2020.
5. Melmed S. The pituitary. 4th ed. London: Academic Press; 2017.
6. Ho KK, Savage MO. Growth hormone and pituitary disorders. Lancet. 2019;393(10170):456-469.
7. Freda PU, Beckers AM. Pituitary adenomas and hyperpituitarism. N Engl J Med. 2020;382:1470-1481.
8. Colao A, Bronstein MD. Clinical practice: Management of pituitary disorders. Nat Rev Endocrinol. 2019;15:478-493.
9. Molitch ME. Disorders of the anterior pituitary. N Engl J Med. 2003;349:1738-1751.
10. Casarini AP, et al. Hypothalamic-pituitary axis: Physiology and pathophysiology. Endocr Connect. 2021;10:R117-R132.